Ohio State Navbar


Susan L. Koletar, MD, FACP

Staff photo

410 W 10th Ave
Columbus, OH 43210

Phone: (614) 293-8732

Email: koletar.1@osu.edu


Current OSU Appointments

Professor-Clinical, Infectious Diseases

Physician, FGP-Infectious Diseases



1984 - present Medical Boards: National Board of Medical Examiners
1987 - present Board Certified: American Board of Internal Medicine
1988 - present Board Certified: American Board of Internal Medicine
1984 - 1998 Stste Medical License: West Virginia Board of Medicine
2006 - 2008 State Medical License: State Medical Board of Ohio

Chapters in Books

Mitral Valve Prolapse and Infective Endocarditis


Concepts in Antimicrobial Therapy: Antimicrobial Mechanisms of Action.

Mitral Valve Prolapse and Infective Endocarditis

Concepts in Antimicrobial Therapy: Antimicrobial Mechanisms of Action

Meningitis, Acute Bacterial

Meningitis, Aseptic


Sarvepalli SK, Koletar SL



Third-trimester maternal toxicity with nevirapine use in pregnancy

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects

Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir



1979 B.A., West Virginia University

1983 M.D., West Virginia University

1986 None Indicated, West Virginia University

1988 None Indicated, Ohio State University College of Medicine


Editorial Activities

present International Journal of STD & AIDS
present HIV Medicine
present Clinical Infectious Diseases
present AIDS Research and Human Retroviruses
present Journal of Antimicrobial Chemotherapy
present Infectious Diseases in Clinical Practice
1995 - 2001 Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics


present Phi Beta Kapa.
1986 Internal Medicine Teaching Award. Department of Internal Medicine.
1993 College of Medicine Faculty Teaching Award. College of Medicine.
1994 College of Medicine Faculty Teaching Award. College of Medicine.
1995 College of Medicine Professor of the Year. College of Medicine.
2002 - present Master Teacher Award. American College of Physicians - American Society of Internal Medicine (Ohio Chapter).
2005 - 2006 America's Best Doctors. US news and World Report.
2007 - 2008 America's Best Doctors. U.S. News & World Report.
2008 - 2009 America's Best Doctors. U.S. News & World Report.
2009 - 2010 America's Best Doctors. U.S. News & World Report.
2010 - 2011 America's Best Doctors. U.S. News & World Report.
2011 - 2012 America's Best Doctors. U.S. News & World Report.
2012 - 2013 America's Best Doctors. U.S. News & World Report.

Journal Articles

"Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution." HIV MEDICINE. Vol. 10, no. 5. (May 2009.): -.

"Tuberculoma of the central nervous system." JOURNAL OF CLINICAL NEUROSCIENCE. Vol. 20, no. 10. (October 2013.): -.


Reference Works

October 1985 Koletar SL, Georgiev MT and RF Hoy."The Effect of Low-Dose Aspirin on Serum Lipids" .
October 1988 Fass RJ and SL Koletar."Treatment of Severe Gram-Negative Osteomyelitis with Oral Ciprofloxacin." .
September 1989 Koletar SL, Russell JA, Fass RJ, and JF Plouffe."A Comparison of Fluconazole with Clotrimazole Troches as Treatment for Oropharyngeal Thrush in Patients with HIV Infection" .
October 1990 Pons VG, Greenspan D, Koletar SL, DeBruin MF, and the Multicenter Study Group."Comparative Study of Fluconazole and Clotrimazole Troches for the Treatment of Oral Thrush in AIDS" .
October 1992 Koletar SL, O’Grady NP, and MF Para."A Cluster of Cases of Disseminated Histoplasmosis in HIV-infected Prisoners" .
June 1993 Koletar SL, and NP O’Grady."Treatment of Disseminated Histoplasmosis" .
December 1993 Berry A, Koletar SL, and D Williams."Azithromycin Therapy for Disseminated Mycobacterium avium-intracellulare in AIDS Patients" .
December 1993 Koletar SL, Weed HG, and MB Ramundo."Thrush Unresponsive to Treatment with Fluconazole in HIV-infected Patients" .
January 1994 Koletar SL, Williams D, and A Berry."Serum Level and MIC do not Correlate with the Efficacy of Azithromycin for Disseminated Mycobacterium avium-complex (MAC) Infection in Patients with AIDS" .
October 1994 Ramundo MB, and SL Koletar."Invasive Aspergillus Infections in AIDS Patients" .
October 1994 Koletar SL."Azithromycin Improves Survival in AIDS Patients with Disseminated Mycobacterium avium-complex (MAC)." .
November 1994 Mabee CL, Mabee SW, and SL Koletar."Hepatic Dysfunction: A Risk Factor for Cryptococcal Peritonitis" .
September 1995 Koletar SL, Buesching WJ, and RJ Fass."Emerging Resistance to Fluconazole Among Blood and CSF Cryptococcus neoformans Isolates" .
November 1995 Murry A and SL Koletar."Listerial Infections: An Exploration of Presentation, Treatment, and Future Directions" .
September 1995 Fichtenbaum C, Koletar S, Yiannoutsos C, Chen D, Pottage J, Kobayshi G, Powderly W, for the ACTG 816 Team."Predictors of Fluconazole Resistant Candida in Advanced HIV Infection" .
November 1995 Koch CA, Mabee CL, Robyn JA, Koletar SL and EN Metz."Exposure to Domestic Cats: Risk Factor for Pasteurella multocida Peritonitis in Liver Cirrhosis and Squamous Cell Cancer of the Head and Neck?" .
July 1996 Fichtenbaum C, Koletar S, Yiannoutsos C, Chen D, Cohn S, Pottage J, Kobayshi G, Powderly W, for the ACTG 816 Team."Fluconazole Resistant Mucosal Candidiasis in Advanced HIV Infection" .
September 1996 Saravolatz L, Mitsuyasu R, Sneller M, MacArthur RD, Koletar SL, Markovitz N, Donabedian H, Lane HC, Fyfe G.."Duration of Proleukin IL-2 Therapy Is More Important Than Total Dose in Achieving CD4 Expansion" .
September 1996 Murry AR, Jackson BM, Maher WE, and SL Koletar."Burkholderia cepacia: An Emerging Pathogen" .
September 1996 Koletar, SL and JA Russell."Characteristics of Patients >50 Years of Age with Newly Diagnosed HIV Infection" .
May 1998 Koletar SL."Opportunistic Infections in AIDS Patients" .
May 1998 Haberland C, Allen C, Beck M, Buesching W, Koletar S, Sundstrom P."Prevalence of fluconazole resistant strains of Candida sp. in outpatients" .
September 1999 Keeling TC, Koletar SL."Candida glabrata Urinary Tract Infections in ICU Patients" .
February 1999 Fichtenbaum C, Ignatov A, Mersman D, Keath E, Koletar S, Powderly W for the ACTG 816 Team."The Molecular Epidemiology of Fluconazole Refractory Oral Candidiasis" .
September 1999 Currier JS, Williams PL, Koletar SL, Murphy RL, Cohn S, Heald A, Knirsch C, Taylor J, Colqhoun D, Nevin T, Hafner R, McCutchan JA.."A Randomized, Placebo-Controlled Trial of Azithromycin Prophylaxis for the Prevention of Mycobacterium avium Complex (MAC) in Subjects with Increases in CD4 Cells on Antiretroviral Therapy" .
February 2000 Koletar SL, AE Heald, RL Murphy, R Hafner, T Nevin, J Taylor and D Finkelstein for the ACTG 888 Team."Discontinuing Primary and Secondary PCP Prophylaxis in Patients Who Have Increased CD4 Counts in Response to Antiretroviral Therapy: Preliminary Results– ACTG 888" .
February 2000 MacGregor RR, Perlman DC, Murphy R, Inderlied C, Andersen J, Bassily E, Koletar SL, Peterson D, Hafner R and the ACTG341 Study Team."Frequency of Isolation of M. avium complex (MAC) from Marrow in Patients Suspected of Disseminated MAC (DMAC) But With Negative Blood Cultures." .
February 2000 Koletar SL, JS Currier, PL Williams, R Hafner, RL Murphy, S Cohn, C Knirsch, T Nevin, and JA McCutchan for the ACTG 362 Team."Prevention of Opportunistic Infections Other than Mycobacterium avium Complex (MAC) in a Randomized, Placebo-Controlled Trial of Azithromycin (AZ) Prophylaxis in Subjects with Increases in CD4 Cells on Antiretroviral Therapy (ART) - Preliminary Results" .
April 2000 Murphy R, Andersen J, Peterson D, Koletar SL, Benson C, Hafner R, Perlman D, Bassily E, MacGregor R for the ACTG 341 Team."Sustained Virologic Response to Triple Class Antiretroviral Therapy in HIV-infected Subjects at risk for Mycobacterium avium complex Disease" .
September 2000 Gastaldo JM, Neidig JL, Para MF, Diaz PT, Koletar SL."The clinical significance of the drug interaction between protease inhibitors and midazolam" .
October 2000 Janssen W, Koletar SL."Lactic acidosis and hepatic steatosis in a woman with HIV infection" .
February 2002 Koletar SL, Wu J, McCutchan JA, Williams PL, Murphy RL, Nevin T, and Currier JS for the ACTG 362 Team."Long-term follow-up of HIV-infected individuals who have experienced immune reconstitution following severe immunosuppression" .
February 2003 Wohl DA, Pilcher CD, Revuelta M, McComsey G, Koletar SL, Evans S, Yijun Y, Zackin R, Alston B, Welch S, Basar M, Kashuba A, Kondo P., Quinn J, and Wingfield H."Absence of Sustained Hyperlactatemia Among HIV-Infected Patients with Risk Factors for Mitochondrial Toxicity" .
September 2003 Goldman M, Zackin R, Fichtenbaum CJ, Wheat LJ, Koletar SL, Skiest DJ, Schnizlein-Bick CT, Hafner R, Nyangweso P, Yiannoutsos C, Andersen JW, Owens S, Hogg E, Aberg JA."Discontinuation of Antifungal Therapy for Disseiminated Histoplasmosis (DH) following Immunologic Response to Antiretroviral Therapy (ART) is Safe: AIDS Clinical Trials Group Study A5038" .
February 2004 McCutchan JA, Wu J, Williams PL, Robertson K, Ellis R, Koletar SL, Currier JS and the ACTG 362 Study Team."Improved Cognitive Function in Immune Reconstituted Advanced AIDS Patients Is Associated with Maintenance of HIV Suppression" .
March 2005 Joy SD, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, Fan-Havard P."Third Trimester Maternal Toxicity with Nevirapine Use in Pregnancy" .
February 2005 Williams P, Wu J, Cohn S, Koletar SL, McCutchan JA, Murphy R, & Currier JS for the ACTG 362 Team."Risk of Cardiovascular Disease (CVD) in HIV-infected Adults with Immune Reconstitution" .
October 2005 Franco A, Joy S, Kang S, Poi M, Hunkler J, Brady M, Koletar S, Para M, Fan-Havard P."Maternal and Newborn Outcomes in a Multidisciplinary HIV Pregnancy Program" .
April 2006 Peters J, Franco A, Joy SD, Hunkler J, Brady MT, Koletar SL, Para MF, Lamberjack K, and Fan-Havard, P."Maternal, Newborn, and Placental Outcomes in a Multidisciplinary HIV Pregnancy Program" .
February 2006 Gupta S, Rosenkranz SL, Segal Y, Koletar SL, Basar M, Szczech L, Amorosa V, Hall S.."The Steady-state Pharmacokinetics (PK) of Efavirenz (EFV) and Lopinavir/Ritonavir (LPV/RTV) in HIV-infected Persons Requiring Hemodialysis: AIDS Clinical Trials Group Study A5177" .
February 2006 Smurzynski M, Collier AC, Koletar SL, Wu K, Bosch RJ, Benson CA."Opportunistic Infections Occurring after Initiation of Randomized HAART Regimens in Treatment-naïve HIV-1 Infected Patients Followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) Study" .
July 2007 Gupta SK, Komarow L, Gulick RM, Pollard RB, Robbins GK, Franceschini N, Szczech LA, Koletar SL, Kalayjian RC."Proteinuria, Creatinine Clearance, and Immune Activation in HIV-Infected Subjects: A Secondary Analysis of Treatment-Naïve Studies ACTG 384, A5095, and A5001" .
February 2007 Acosta EP, Kendall MA, Gerber JG, Suckow C, Koletar SL, Zolopa AR, Laughlin L, Agarwala S, Child MJ, Haas DW, for the A5213 Study Team."Effect of Rifampin on Pharmacokinetics and Safety of Twice-Daily Atazanavir: ACTG Protocol A5213" .
February 2008 Koletar SL, Smurzynski M, Wu K, Collier AC, BoschRJ, Benson CA."Opportunistic Infections Occurring in Treatment-Experienced HIV-1 Infected Patients Followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) Study" .
March 2008 Ribaudo HJ, Collier AC, Koletar SL, Smurzynski M, Zheng Y, Bosch RJ, Benson CA.."Risk Factors Associated with Serious Non-AIDS-Defining Events (NADE) Following Treatment Initiation in Antiretroviral Naïve Individuals Enrolled in the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Study" .
February 2008 Haas DW, Koletar SL, Laughlin L, Kendall MA, Suckow C, Gerber JG, Zolopa AR, Bertz R, Child MJ, Acosta EP for the A5213 Study Team."Hepatic Transaminase Elevations and Gastrointestinal Intolerance when HIV-Negative Healthy Volunteers on Rifampin (RIF) add Twice-Daily Atazanavir (ATV 300 mg)/Ritonavir (RTV 100 mg): ACTG Protocol A5213" .
February 2008 Day SR, Koletar SL, Mangino JE, Stevenson KB, Para MF.."The Effect of Chronic Trimethoprim/sulfamethoxazole (TMP/SMX) Use on Nasal Carriage of Staphylococcus aureus in HIV Infected Patients" .
April 2008 Acree ME, Jason C, Tshiamala M, Koletar SL.."Occupational Stress in Zambian Palliative Care Nurses: Emphasis of Care in a Resource-Limited Setting." .
April 2009 Cohn SE, Williams PL, Jiang HJ, McCutchan JA, Koletar SL, Robertson KR, deStMaurice A, Murphy RL, Currier JS and ACTG 362 Team."Ongoing Illicit Drug Use Predicts Non-adherence to Antiretroviral Therapy and Higher Risk of AIDS and Death: Results from ACTG 362." .
February 2009 Chow D, Chen H, Glesby MJ, Busti A, Souza S, Kohrs S, Wu J, Andersen J, Koletar SL."Ezetimibe is Safe and Effective in Combination with Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects: Results of ACTG Protocol A5209" .
April 2009 Cohn SE, Williams PL, Jiang JH, McCutchan JA, Koletar SL, Robertson KR, deStMaurice A, Murphy RL, Currier JS."Ongoing Substance Use Predicts Non-Adherence to Antiretroviral Therapy and Higher Risk of AIDS and Death: Results from ACTG 362" .
January 2009 Brawner E, Browning K, Harness J, Reynolds N, Ferketich A, Drake J, Koletar S, Diaz P, Wewers ME.."Smoking Cessation in the HIV Seropositive Population" .
February 2009 Benson CA, Zheng E, Ribaudo H, Koletar SL, Collier A, Smurzynski M, Bosch R, Bastow B, Schouten J for the ACTG A5001/ALLRT Protocol Team."No Association of Abacavir (ABC) Use with Risk of Myocardial Infarction (MI) or Severe Cardiovascular Disease Events (SCVD): Results from ACTG A5001/ALLRT" .
October 2009 Narla R, Martin SI, Koletar, SL."Severe Group A Streptococcus Infections – Presentation, Pathology and Immunotherapy" .
July 2010 Koletar SL, Hartley D, Bosch R, Patton, L, Pavlov G, Bartlett, JA for the Performance Evaluation Committee of the ACTG.."Performance Evaluation Metrics and Standards Developed by the AIDS Clinical Trials Group (ACTG) Network" .
March 2010 Krishnan S, Wu K, Smurzynski M, Bosch R, Benson CA, Collier AC, Koletar SL for the ALLRT/A5001 team."Incidence rate (IR) and factors associated with loss-to-follow-up (LTFU) in a longitudinal study of HIV-infected subjects receiving antiretrovirals: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis" .
March 2012 Wohl DA, Arnoczy G, Fichtenbaum C, Campbell T, Taiwo B, Hicks C, McComsey GA, Koletar SL, Sax P, and Stein J.."Cardiovascular Disease (CVD) Risk Markers in Patients Receiving Abacavir, Tenofovir, and Zidovudine: The Nucleoside Inflammation, Coagulation and Endothelial Function (NICE) Study." .
March 2012 Taiwo B, Yanik E , Napravnik S, Ryscavage P, Koletar SL, Moore R, Kahn J, Matthews CW, Crane H, Eron JJ on behalf of the CFAR Network of Integrated Clinical Systems (CNICS) Cohort Study.."Laboratory Abnormalities Following Initiation of Modern ART in the US, 2000-2010 among the CNICS Cohort." .


New Beta-Lactam Antibiotics

HIV Infection-Management Issues

Common Opportunistic Infections Seen in AIDS Patients


HIV Infection-Management After Diagnosis

An Update on Quinolones

Current Role of Empiric Antibiotic Therapy

Approach to Rational Use of Antibiotics


New Antifungal Agents

HIV and Fungus

An Update on Quinolones

HIV/AIDS: New Treatments and Therapies

Antiviral Therapy in Immunocompromised Patients with Chest Problems in the Intensive Care Unit

Management of the HIV-Infected Patient

Management of the HIV-Infected Patient

AIDS: New and Emerging Treatments

HIV-Infection: Opportunistic Infections

Fungal Infections in HIV-Positive Patients

Fungal Infections in HIV-infected Patients

Commonly Encountered Infections in the Outpatient Setting

Chronic Fatigue Syndrome - An Update

Infectious Complications of AIDS

Emergency Management of Infections in the Immunocompromised Host

Care of the Asymptomatic HIV-infected Patient

Update on Tuberculosis

Fungal Infections in HIV-Positive Patients

AIDS Update: Treatment and Legalities

Update on Tuberculosis

Update on Infectious Diseases

Azithromycin as Treatment for Disseminated MAC: Results of Monotherapy Trials

Emerging Problems with Resistant Candida Species

Immunizations of Interest to Military Personnel

Tuberculosis in the 1990’s

Mycobacterium avium Complex: Therapeutic Options

Management of Opportunistic Infections in AIDS

Tuberculosis Update

Current Treatment of Fungal Infections

HIV Update

Cardiovascular Infections and Infections Associated with Cardiothoracic Surgeries

Azithromycin Treatment Trials

AIDS Update: Focus on Occupational Risks

Infectious Diseases Potpourri: Changing Trends, New Treatments

Current Treatment for Fungal Infections: Dermatophytoses, Urinary Tract Infections, and Candidemia

Central Nervous System Infections

Impact of Discontinuing PCP Prophylaxis in Subjects Receiving Antiretroviral Therapies Who Have Had Increases in CD4 Counts to >200 Cells/mm3

Case Studies in the Prophylaxis of MAC

Update on Prophylaxis and Treatment of Mycobacterium avium Complex

Medical Update

Effective Treatment for Fungal Infections in HIV-Infected Patients

AIDS Update

AIDS Update ‘97: Opportunistic Infections

An Update on HIV Infection

Opportunistic Infections in AIDS Patients

Nosocomial Candida Infections

Issues Affecting Women with HIV/AIDS

Immune Reconstitution in the Current Era of AIDS Care


Treatment of Pneumocystis carinii Pneumonia

Complications of HIV Infection and HIV Therapies

Fungal Infections: A Case-Based Assessment

AIDS Update

The Range of Immune Recovery Responses

Evolving Treatment Strategies in HIV Infection

HIV Treatment Update: The Next Generation

AIDS Update 2005

A5082: A Randomize, Double-Blind, Placebo-Controlled Study of Metformin and Rosiglitazone Alone or in Combination, in HIV-Infected Subjects with Hyperinsulinemia and Elevated Waist/Hip Ratio

Things We All Should Know About HIV/AIDS

HIV Update – What Internists Should Know about HIV/AIDS

HIV Issues in Primary Care Medicine

Advances in the Diagnosis and Management of HIV/AIDS

Treating HIV in Older Adults

HIV/AIDS Update: Serving Underserved Populations

Use of Newer Vaccines in Healthy and Immunocompromised Adults

Update from the XVIII International AIDS Conference

Managing HIV Co-Infections and Co-Morbidities: A Case-Based Panel Discussion

HIV Infection – An Important Issue in Women’s Health


Immunization update.



Professional Activities

present "The Suprising Region Where HIV is on the Rise". Yahoo! Health - Online audience 12.4 million. Columbus, OH.
present Publications Committee. Infectious Diseases Society of America. Arlington, VA.
2010 - present Writing Committee for the IDSA In Training Exam. Infectious Diseases Society of America.
2011 - present Infectious Diseases Society of America.
2009 - 2011 Reviewer. California HIV Research Program Study Section.